Results for “protein synthesis”
Molecular Biology
** Molecular biology deciphers the structures and chemical processes of nucleic acids and proteins that drive cellular function and inheritance. **CONTENT:** ## Overview Molecular biology is the **science of life at the molecular level**, focusing on how DNA, RNA, and proteins interact to store, transmit, and execute genetic information. By probing the **three‑dimensional structures** of macromolecules—often at resolutions of **~3 Å**—researchers can link atomic detail to biological outcome. Central processes such as **replication**, **transcription**, **translation**, and **post‑translational modification** are examined not merely as abstract pathways but as dynamic, physically measurable events. For example, a single human cell contains roughly **6 × 10⁹ base pairs** of DNA and synthesizes **~10⁴ distinct proteins**, each averaging **~50 kDa** in mass. The field is inherently interdisciplinary. Classical genetics supplies the phenotypic context, biochemistry provides the reagents and reaction mechanisms, physics contributes quantitative models of molecular motion, and mathematics offers statistical frameworks for interpreting large data sets. Since the turn of the millennium, **bioinformatics** and **computational biology** have become indispensable, enabling the analysis of **petabyte‑scale sequencing data** and the simulation of protein folding on supercomputers. In practice, a molecular biologist may move seamlessly from a **PCR thermocycler** to a **cryo‑EM microscope** to a **cloud‑based genome browser**, illustrating the field’s breadth. ## History/Background The conceptual roots of molecular biology trace back to the **mid‑20th century**. In **1953**, James Watson and Francis Crick unveiled the **double‑helix structure of DNA**, a discovery that earned the Nobel Prize in 1962 and set the stage for mechanistic studies. The **1960s** saw the formulation of the **central dogma**—DNA → RNA → Protein—by Francis Crick, crystallizing the flow of genetic information. The **1970s** introduced recombinant DNA technology, with **1972** marking the first successful insertion of a gene into a bacterial plasmid (Cohen & Boyer). This breakthrough birthed **genetic engineering**, allowing scientists to manipulate genomes at will. The **1980s** brought the polymerase chain reaction (PCR), invented by Kary Mullis in **1983**, which amplified specific DNA fragments exponentially, revolutionizing diagnostics and research. The **1990s** witnessed the **Human Genome Project**, launched in **1990** and completed in **2003**, delivering a reference sequence of **≈3.2 billion base pairs**. The post‑genomic era, beginning in the early **2000s**, has been defined by high‑throughput sequencing, CRISPR‑Cas genome editing (first demonstrated in **2012**), and single‑cell transcriptomics, each expanding the molecular toolkit dramatically. ## Key Information - **Macromolecules:** DNA (deoxyribonucleic acid), RNA (ribonucleic acid), proteins, and increasingly, **non‑coding RNAs** and **ribozymes**. - **Core Processes:** - **Replication:** Semi‑conservative copying of DNA; fidelity ≈ 1 error per **10⁹** nucleotides, corrected by proofreading enzymes. - **Transcription:** Synthesis of RNA by RNA polymerase; regulated by promoters, enhancers, and epigenetic marks (e.g., **5‑methyl‑cytosine**). - **Translation:** Ribosomal assembly of polypeptides; each ribosome can add **~20 amino acids per second** in *E. coli*. - **Techniques:** PCR, gel electrophoresis, Sanger and next‑generation sequencing (NGS), CRISPR‑Cas9 editing, X‑ray crystallography, cryo‑electron microscopy (cryo‑EM), mass spectrometry, and single‑molecule fluorescence. - **Achievements:** Production of **insulin** via recombinant *E. coli* (1978), development of **mRNA vaccines** for COVID‑19 (2020), and the mapping of **protein‑protein interaction networks** encompassing **>10⁶** edges in model organisms. ## Significance Molecular biology underpins modern medicine, agriculture, and biotechnology. By revealing the **molecular basis of disease**, it enables targeted therapies such as **tyrosine‑kinase inhibitors** for chronic myeloid leukemia and **antisense oligonucleotides** for spinal muscular atrophy. In agriculture, transgenic crops engineered for **Bt toxin** expression or **herbicide resistance** have increased yields for over **200 million** hectares worldwide. The field also fuels **synthetic biology**, where engineered genetic circuits produce bio‑fuels, biodegradable plastics, and novel therapeutics. Beyond applications, molecular biology reshapes our philosophical view of life, showing that **information**—encoded in nucleic acids—behaves analogously to **digital code**, subject to error correction, encryption, and evolution. Its legacy is a **global research ecosystem** of databases (GenBank, PDB), standards (FAIR data principles), and collaborative consortia that accelerate discovery at an unprecedented pace. **INFOBOX:** - Name: Molecular Biology - Type: Biological Science Discipline - Date: Established 1953 (DNA double helix discovery) - Location: International (research institutions worldwide) - Known For: Elucidating the central dogma and enabling recombinant DNA technology **TAGS:** genetics, biochemistry, genomics, protein synthesis, bioinformatics, CRISPR, recombinant DNA, cellular biology
ScienceRibosomes
** The ribosome is a universal ribonucleoprotein machine that reads messenger RNA and polymerizes amino acids into proteins, driving the core of cellular life. **CONTENT:** ## Overview The **ribosome** is a colossal ribonucleoprotein particle present in every living cell, from the simplest bacteria to the most complex eukaryotes. Structurally it is composed of two subunits—a **small subunit** that decodes the genetic message carried by **messenger RNA (mRNA)**, and a **large subunit** that catalyzes the formation of peptide bonds between **amino acids**. In prokaryotes the pair is termed a **70S ribosome** (30S + 50S), while eukaryotic ribosomes are larger, **80S** (40S + 60S). Each subunit contains multiple **ribosomal RNA (rRNA)** molecules—rRNA accounts for roughly 60 % of the ribosome’s mass—and dozens of **ribosomal proteins** that stabilize the complex and assist in its dynamic motions. During **translation**, the ribosome moves along the mRNA in a stepwise fashion, reading each **codon** (a three‑nucleotide sequence) and matching it with the appropriate **transfer RNA (tRNA)**‑charged amino acid. The large subunit’s peptidyl transferase center, an RNA‑catalyzed active site, forms a new **peptide bond**, extending the nascent **polypeptide chain**. This process is highly coordinated: initiation factors assemble the ribosome on the start codon, elongation factors shuttle tRNAs into the A‑site, and release factors terminate synthesis when a stop codon is encountered. The entire cycle can synthesize a protein at a rate of 10–20 amino acids per second in bacteria and slightly slower in eukaryotes. Ribosomes are not static; they undergo conformational changes that resemble a tiny mechanical engine. Cryogenic electron microscopy (cryo‑EM) studies have captured these motions at resolutions better than **2.5 Å**, revealing how the **L1 stalk**, **tRNA**, and **mRNA** pivot during each translocation step. The ribosome’s size—roughly **20–30 nm** in diameter—makes it one of the largest macromolecular complexes in the cell, yet it operates with the precision of a molecular clock. ## History/Background The story of ribosome discovery began in the 1950s when **Albert Claude** and **George Palade** identified dense particles in the cytoplasm of pancreatic cells, coining the term “**ribosome**” in 1958. The first electron micrographs, published in **1955**, showed the characteristic “sand‑like” texture that hinted at a complex assembly. In the **1960s**, **Ribosomal RNA** was isolated, and **K. R. Kurland** demonstrated that ribosomes could be separated into distinct subunits by ultracentrifugation, establishing the **70S** (prokaryotic) and **80S** (eukaryotic) nomenclature. The 1970s ushered in the era of **X‑ray crystallography**. In **1974**, the structure of the **30S subunit** from *Thermus thermophilus* was solved to 12 Å, providing the first glimpse of the ribosome’s architecture. The breakthrough came in **2000** when **Ada Yonath**, **Thomas Steitz**, and **Venkatraman Ramakrishnan** each achieved high‑resolution crystal structures of the **70S ribosome**, earning the **2009 Nobel Prize in Chemistry**. Their work revealed that the ribosome’s catalytic core is RNA, confirming the **RNA world hypothesis**. Since then, advances in cryo‑EM have pushed resolution to atomic detail, culminating in the **2020** “**ribosome atlas**” that maps every functional state across all domains of life. ## Key Information - **Composition:** Prokaryotic 70S = 30S (16S rRNA + ≈ 21 proteins) + 50S (23S + 5S rRNA + ≈ 34 proteins). Eukaryotic 80S = 40S (18S rRNA + ≈ 33 proteins) + 60S (28S + 5.8S + 5S rRNA + ≈ 49 proteins). - **Size:** ~20 nm (small subunit) + ~25 nm (large subunit); overall mass ≈ 2.5 MDa in bacteria, ≈ 4.3 MDa in eukaryotes. - **Catalysis:** Peptidyl transferase activity resides in the **23S/28S rRNA**, making the ribosome a **ribozymal enzyme**. - **Speed:** Bacterial ribosomes add ~15 aa · s⁻¹; eukaryotic ribosomes ~5–10 aa · s⁻¹. - **Antibiotic Targets:** Many antibiotics (e.g., **tetracycline**, **chloramphenicol**, **erythromycin**) bind specific rRNA pockets, inhibiting bacterial translation without affecting eukaryotic ribosomes. - **Regulation:** Ribosome biogenesis consumes up to **30 %** of cellular energy in rapidly dividing cells; it is tightly coordinated by transcription factors (e.g., **Myc**) and signaling pathways (e.g., **mTOR**). - **Disease Links:** Mutations in ribosomal proteins cause **ribosomopathies** such as **Diamond‑Blackfan anemia**; dysregulated ribosome production is a hallmark of many cancers. ## Significance Ribosomes are the **central hub of gene expression**, converting the static information encoded in DNA into functional proteins that perform every cellular task—from metabolism to signaling. Their universal presence makes them a cornerstone of evolutionary biology; the conserved core of rRNA across all domains of life provides a molecular clock for phylogenetic studies. In medicine, ribosomes are a prime target for antibiotics, and their dysregulation underlies a spectrum of human diseases, offering avenues for therapeutic intervention. Moreover, the ribosome’s RNA‑based catalysis supports the **RNA world hypothesis**, suggesting that early life may have relied on ribozyme machines before proteins emerged. Understanding ribosome structure and function continues to drive innovations in synthetic biology, where engineered ribosomes are being repurposed to incorporate non‑canonical amino acids, expanding the chemical repertoire of living systems. **INFOBOX:** - Name: Ribosome (Ribonucleoprotein Particle) - Type: Cellular molecular machine / Translational apparatus - Date: First identified 1955; structural breakthrough 2000 (Nobel‑winning) - Location: Cytoplasm (free) and rough endoplasmic reticulum (membrane‑bound) in eukaryotes; cytosol in prokaryotes - Known For: Catalyzing protein synthesis by translating mRNA into polypeptide chains **TAGS:** ribosome, translation, ribonucleoprotein, mRNA, protein synthesis, molecular biology, antibiotics, ribosomopathies